Bloomberg
Dr. Reddy’s Sees Weight-Loss Drug Boosting Growth After Setback
Dr. Reddy’s Laboratories Ltd. expects its generic anti-obesity drug to shore up growth in the six months through March after it resolves an impurity issue with the key ingredient and resumes supply in early November.
View original source — Bloomberg ↗
Related stories
ABC News
BusinessJul 30, 2026 · 1 min
'Take them seriously': CFMEU administrator on Setka threats
ABC News
Rio Times
BusinessJul 30, 2026 · 1 min
COLCAP: Latest Close, Performance and Daily Colombia Report
Rio Times
Rio Times
BusinessJul 30, 2026 · 1 min
S&P Merval: Latest Close, Performance and Daily Report
Rio Times
Rio Times
BusinessJul 30, 2026 · 1 min
S&P IPSA: Latest Close, Performance and Daily Chile Report
Rio Times